Journal
JOURNAL OF CELL BIOLOGY
Volume 199, Issue 4, Pages 583-588Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.201210077
Keywords
-
Categories
Ask authors/readers for more resources
The proteasome is the primary site for protein degradation in mammalian cells, and proteasome inhibitors have been invaluable tools in clarifying its cellular functions. The anticancer agent bortezomib inhibits the major peptidase sites in the proteasome's 20S core particle. It is a blockbuster drug that has led to dramatic improvements in the treatment of multiple myeloma, a cancer of plasma cells. The development of proteasome inhibitors illustrates the unpredictability, frustrations, and potential rewards of drug development but also emphasizes the dependence of medical advances on basic biological research.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available